Pneumonia Testing Market

POC Testing is Becoming more Popular with its Speed Response to Pneumonia Testing

Point-of-care (POC) testing is a new tool that is now the best way to identify pneumonia. POC testing is becoming more popular due to its improved efficiency, increased cases of pneumonia, and rapid test results, which make it very favourable. As a result of the increased prevalence of chronic pneumonia diseases in a wide customer base, the adoption of cost-effective and quick diagnostic tests is accelerating point of care testing, thus driving the growth of the pneumonia testing market. In 2019, Pneumonia claimed the lives of 2.5 million people and due to the COVID-19 pandemic, this number climbed up to 4 million in 2020.  With the continuous increase in the number of patients and the ongoing pandemic, the use of POC testing can help in reducing the prevalence of chronic pneumonia diseases with early diagnosis.

The ability of POC tests to provide speedy and accurate findings in minimal time aids in the promotion of patient-centred healthcare in bedside settings, which leads to the adoption of point of care testing and hence the rise of the pneumonia testing market. This is stirring various market competitors to scale their production and promote technological advancement in the POC testing method. For instance, in 2021, the Panbio COVID-19 Antigen Self-Test was developed by Abbott, which can identify the SARS-CoV-2 virus in adults and children. With the help of this test kit, it is anticipated that the early diagnosis of COVID-19 will increase, which will help to curb the cases of Pneumonia.

Enzyme-Linked Immunosorbent Assay (ELISA) Dominated Market Due to its Varied Range of Application

Enzyme-linked immunosorbent assay (ELISA) dominates the technology section of the pneumonia testing market. The occurrence of infectious diseases such as dengue, hepatitis, AIDS, neurological disorders, and cancer is driving the demand for ELISA in the forecast period. It is also used in toxicology, vaccine development, immunology, drug monitoring, transplantation, pharmaceuticals, infectious illnesses, cancer, protein quantification, and a variety of other applications. Due to its great healthcare infrastructure and better research and development facilities, North America is a significant region dominating ELISA technology.

North America Dominated Pneumonia Testing Market due to Growing Number of Infections

North America is expected to have the highest pneumonia testing market share during the forecast period, owing to the prevalence of chronic diseases, an increase in healthcare expenditure, the presence of advanced healthcare infrastructure, availability of reimbursements, and the presence of major market players in the region. According to CDC, there were a total of 47,601 death in the US in 2020 with a ratio of 14.4:1000 patients. Such a huge prevalence of Pneumonia in the region is expected to boost the market demand for the pneumonia testing kit in the region.

Asia Pacific may also see an increase of the pneumonia testing market over the forecast period due to a rise in health care awareness and increasing demand for modern medical technology in the region. The rising prevalence of infectious and chronic diseases in the Asia Pacific is expected to drive the adoption of these diagnostics. For instance, in India, approximately 3.7 lakhs of children within the age of five die due to pneumonia annually. To curb this number of infections, private organisations along with public support are increasing the demand and the need for Pneumonia testing equipment in the country, which is driving the regional market as well. The widespread use of modern POC diagnostics to diagnose numerous chronic and infectious diseases, as well as the availability of advantageous reimbursement policies, are expected to drive growth in the region. Furthermore, the government has invested in R&D to boost the diagnostics sector, particularly in the development of highly advanced point-of-care diagnostic technologies. These elements contribute to the region's market growth.

Global Pneumonia Testing Market: Competitive Landscape

Players in the sector are introducing new products as well as forming collaborations, alliances, and partnership agreements. For instance, in 2021, Abbott created AlinityTM m Resp-4-Plex, a novel assay that tests for COVID-19, flu A, flu B, and RSV using only one swab and runs on our superior Alinity m technology. This test will help the patient with an early diagnosis of pneumonia as well. For instance, in 2021, Thermo Fisher Scientific announced that it has received FDA Emergency Use Authorization (EUA) to execute COVID-19 tests on the Amplitude Solution utilizing a novel saliva sample collecting procedure using the Spectrum Solutions SpectrumDNA SDNA-1000 collection instrument, a high-throughput, automated COVID-19 testing system. Thermo Fisher Scientific believed that it will also provide pneumonia testing as Covid-19 is becoming one of the prominent causes of Pneumonia.

A few of the players in the pneumonia testing market include Abbott Laboratories, F.hoffman La Roche, Thermofischer Inc, Hologic Inc, Biomerieux SA, Quidel Corporation, Bio-Rad laboratories, Beckton and Dickinson Company, AdvanDx, Beckman Coulter.

Global Pneumonia Testing Market is Segmented as Below:

By Types

• Consumables
• Analyzers

By Method

• Molecular Diagnostics
• Point of Care Testing
• Immunodiagnostics

By Technology

• Enzyme-Linked Immunosorbent Assay
• Immunofluorescence
• Western Blot
• Polymerase Chain Reaction
• Immunohistochemistry
• Others

By End-User

• Hospitals
• Diagnostic Laboratories
• Homecare
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • France
  • Germany
  • Russia
  • Rest of Europe
• Asia Pacific
  • Japan
  • South Korea
  • India
  • China
  • Rest of Asia-Pacific
• LAMEA
  • Latin America
  • Middle East
  • Africa

Key Elements Included In The Study: Global Pneumonia Testing Market

• Pneumonia Testing Market by Product/Technology/Grade, Application/End-user, and Region
• Executive Summary (Opportunity Analysis and Key Trends)
• Historical Market Size and Estimates, Value, 2018 - 2021
• Market Value at Regional and Country Level, 2022 - 2029
• Market Dynamics and Economic Overview
• Market Size in Value, Growth Rates, and Forecast Figures, 2022 - 2029
• Competitive Intelligence with Financials, Key Developments, and Portfolio of Leading Companies 
• Regional and Product/Grade/Application/End-user Price Trends Analysis
• Value Chain and Five Force’s Analysis
• Regional/Sub-region/Country Market Size and Trend Analysis
• Company Market Share Analysis and Key Player Profiles

Post Sale Support, Research Updates & Offerings

We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.

• The report will be prepared in a PPT format and will be delivered in a PDF format.

• Additionally, Market Estimation and Forecast numbers will be shared in Excel Workbook.

• If a report being sold was published over a year ago, we will offer a complimentary copy of the updated research report along with Market Estimation and Forecast numbers within 2-3 weeks’ time of the sale.

• If we update this research study within the next 2 quarters, post purchase of the report, we will offer a Complimentary copy of the updated Market Estimation and Forecast numbers in Excel Workbook.

• If there is a geopolitical conflict, pandemic, recession, and the like which can impact global economic scenario and business activity, which might entirely alter the market dynamics or future projections in the industry, we will create a Research Update upon your request at a nominal charge.

Disclaimer:

• The segmentation/company profiles/countries depicted above may vary in the actual report.